Wade J. Sexton

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Naomi B. Haas, Judith Manola, Robert G. Uzzo et al. · The Lancet · 2016 · 625 citations · Full text

Urology, Genitourinary Cancer, Medicine +8

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2020 · 619 citations · Full text

Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

Christopher L. Amling, Robert H. Riffenburgh, Leon Sun et al. · Journal of Clinical Oncology · 2003 · 383 citations · Full text

Bladder Cancer

Peter E. Clark, Neeraj Agarwal, Matthew C. Biagioli et al. · Journal of the National Comprehensive Cancer Network · 2013 · 312 citations · Full text

Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy

Jason C. Massengill, Leon Sun, Judd W. Moul et al. · The Journal of Urology · 2003 · 292 citations